ACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod ® 5 App for iPhone is now compatible with the ...

Insulet Corporation PODD recently made its Omnipod 5 Automated Insulin Delivery (“AID”) System commercially available in Australia. Omnipod 5 is available with Dexcom G6 and G7 continuous glucose ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today made ...

Insulet, which specializes in tubeless insulin pump technology with its Omnipod brand of products, today announced it has received FDA 510(k) clearance for the Omnipod 5 App for iPhone. This makes ...

Omnipod 5 is currently eligible for people aged two years and above with Type 1 diabetes. The tubeless AID system communicates with a continuous glucose monitor (CGM), proactively correcting for highs ...